 |
2011
Developing an international network for breast cancer research: the BIG experience |
| Clinical Investigation 1(5), 623-628, 2011 |
Correlation between docetaxel-induced skin toxicity and the use of steroids and H2 blockers: A multi-institution survey. |
| Kosuke Kawaguchi, Hiroshi Ishiguro, Satoshi Morita, Seigo Nakamura, Shinji Ohno, Norikazu Masuda, Hiroji Iwata, Kenjiro Aogi, Katsumasa Kuroi, Masakazu Toi; Japan Breast Cancer Research Group (JBCRG) |
| Breast Cancer Research and Treatment, 130(2) : 627-634, 2011 |
Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients With Primary Breast Cancer |
| Hiroji Iwata, Nobuaki Sato, Norikazu Masuda, Seigo Nakamura, Naohito Yamamoto, Katsumasa Kuroi, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, and Masakazu Toi |
| Japanese Journal of Clinical Oncology 41: 867-875, 2011 |
2010
Economic evaluation of the 21-gene signature (Oncotype DX(®)) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03). |
| Kondo M, Hoshi SL, Yamanaka T, Ishiguro H, Toi M. |
| Breast Cancer Res Treat. 2010 Nov 17. [Epub ahead of print] |
ALTTO trial |
| Katsumasa Kuroi |
| Cancer Board Breast Cancer 1(1): 58, 2010 |
JBCRG-M02 trial |
| Katsumasa Kuroi |
| Cancer Board Breast Cancer 3(1): 91, 2010 |
JBCRG-07 trial |
| Norikazu Masuda |
| Cancer Board Breast Cancer 3(1): 92, 2010 |
Japan Breast Cancer Research Group (JBCRG) |
| Kuroi K, Kashiwa K, Toi M, Nakamura S, Iwata H, Ohno S, Masuda N, Aogi K, Sato N, Sasano H; Japan Breast Cancer Research Group (JBCRG) |
| Clinical Oncology 2010 Oct; 6(4): 360-368 |
Clinical Significance of the 21-Gene Signature (Oncotype DX) in Hormone Receptor-Positive Early Stage Primary Breast Cancer in the Japanese Population |
| Toi M, Iwata H, Yamanaka T, Masuda N, Ohno S, Nakamura S, Nakayama T, Kashiwaba M, Kamigaki S, Kuroi K; and the Japan Breast Cancer Research Group-Translational Research |
| Cancer 2010, July 1: 3113-3118 |
2009
The new approach of the preoperative therapy for breast cancer – Steps of JBCRG study |
| Hiroyasu Yamashiro, Masakazu Toi |
| Igaku no ayumi Vol 230, No1,p57-61, 2009 |
SUPREMO(BIG2-04) Trial. |
| Katsumasa Kuroi |
| Cancer Board Breast Cancer 2(1): 68, 2009. |
CREATE-X (JBCRG-04) Trial. |
| Norikazu Masuda |
| Cancer Board Breast Cancer 2(1) 70, 2009. |
'Preoperative Chemotherapy ; Evaluation of Response' - Understanding of Breast Cancer: Basics and Clinics (Edited by Masakazu Toi)- |
| Katsumasa Kuroi |
| Iyaku(Medicine and Drug)Journal Co., Ltd., p654-662, 2009 |
An overview of JBCRG activities |
| Katsumasa Kuroi, Masakazu Toi |
| BIG newsletter volume 11 number 1 2009 |
Supremo trial expands into Asia |
| BIG newsletter volume 11 number 2 2009 |
Japan Breast Cancer Research Group (JBCRG) |
| Katsumasa Kuroi |
| European Society of Breast Cancer Specialists – Eusoma Newsletter 2009 |
2008
Review of the study of FEC followed by docetaxel 100mg/m2 as preoperative chemotherapy in primary breast cancer |
| Seigo Nakamura, Norikazu Masuda, Hiroji Iwata, Masakazu Toi, Katsumasa Kuroi, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama; Japan Breast Cancer Research Group (JBCRG). |
| Japanese Journal of Breast Cancer 2008, Vol.23,No.2 :p111-117 |
PhaseII study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival |
| Toi M, Nakamura S, Kuroi K, Iwata H, Ohno S, Masuda N, Kusama M, YamazakiK, Hisamatsu K, Sato Y, Kashiwaba M, Kaise H, Kurosumi M, Tsuda H, Akiyama F,Ohashi Y, Takatsuka Y; for Japan Breast Cancer Research Group (JBCRG) |
| Breast Cancer Res Treat. 2008 Aug;110(3):531-9. Epub 2007 Sep 19 |
2007
Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01) |
| Masuda N, Toi M, Takatsuka Y, Nakamura S, Iwata H, Ohno S, Kuroi K, Kusama M, Hisamatsu K, Yamazaki K, Eisei S, Sato Y, Kaise H, Kashiwaba M,Iwase H, Kurosumi M, Tsuda H, Akiyama F; Japan Breast Cancer Research Group (JBCRG). |
| Gan To Kagaku Ryoho. 2007 Oct; 34(10): 1609-15 (Japanese) |
JBCRG03:Preoperative chemotherapy using Docetaxel 75 mg/m2, followed by FEC 100 mg/m2 - Review of and breakthrough by JBCRG01 and 02 - |
| Masahiro Kashiwaba, Go Wakabayashi, Seigo Nakamura, Katsumasa Kuroi, Hiroji Iwata, Shinji Ohno, Norikazu Masuda, Nobuaki Sato, Taro Asaga, Naohito Yamamoto, Kenjiro Aogi, Yasuyuki Sato, Masafumi Kurozumi, Hitoshi Tsuda, Futoshi Akiyama, Masakazu Toi; Japan Breast Cancer Research Group (JBCRG) |
| Japanese Journal of Breast Cancer 2007,Vol.22 No.5, p372-375 |
2006
Japan Breast Cacer Research Group (JBCRG) Trials Update. |
| Kuroi K, Toi M, Nakamura S, Iwata H, Ohno S, Takatsuka Y; Japan Breast Cancer Research Group (JBCRG). |
| BIG NEWS LETTER 2006,8 (1) |
Issues in the Assessment of the Pathologic Effect of Primary Systemic Therapy for Breast Cancer |
| Kuroi K, Toi M, Tsuda H, Kurosumi M, Akiyama F; Japan Breast Cancer Research Group (JBCRG). |
| Breast Cancer. 2005; 13(1): 38-48. |
2005
Interim analysis of a phaseII trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breastcarcinoma |
| Iwata H, Nakamura S, Toi M, Shin E, Masuda N, Ohno S, Takatsuka Y,Hisamatsu K, Yamazaki K, Kusama M, Kaise H, Sato Y, Kuroi K, Akiyama F, Tsuda H, Kurosumi M; Japan Breast Cancer Research Group (JBCRG). |
| Breast Cancer. 2005;12(2):99-103. |
Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer |
| Ohno S, Toi M, Kuroi K, Nakamura S, Iwata H, Kusama M, Masuda N, Yamazaki K, Hisamatsu K, Sato Y, Takatsuka Y, Shin E, Kaise H, Kurozumi M, Tsuda H, Akiyama F; Japan Breast Cancer Research Group (JBCRG). |
| Biomed Pharmacother.2005 Oct;59 Suppl 2:S323-4. |
Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer. |
| Kuroi K,. Toi M, Tsuda H, Kurosumi M, Akiyama F; Japan Breast Cancer Research Group (JBCRG). |
| Biomed Pharmacother. 2005 Oct;59 Suppl 2:S387-92. |
From the Japan Breast Cancer Research Group (JBCRG): How to define pCR: Our Challenge. |
| Kuroi K, Toi M, Tsuda H, Kurosumi M, Akiyama F; Japan Breast Cancer Research Group (JBCRG). |
| BIG NEWS LETTER 2005, 7(1), |
